TY - JOUR
T1 - Magnetic resonance-guided laser interstitial thermal therapy
T2 - Correlations with seizure outcome
AU - Kang, Joon Y.
AU - Pickard, Allyson A.
AU - Bronder, Jay
AU - Yenokyan, Gayane
AU - Chen, Mo
AU - Anderson, William S.
AU - Sperling, Michael R.
AU - Nei, Maromi
N1 - Funding Information:
We thank Drs. Chengyuan Wu and Ashwini Sharan for conducting the procedures and contributing to the Thomas Jefferson database, Mark Hays for his help with data analysis, and Erie Gonzalez for initial collection of the data. This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant number UL1 TR003098 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH.
Publisher Copyright:
© 2021 International League Against Epilepsy
PY - 2021/5
Y1 - 2021/5
N2 - Objective: This study was undertaken to identify clinical factors associated with seizure freedom after magnetic resonance-guided laser interstitial thermal therapy (MRgLiTT) in temporal lobe epilepsy patients with unilateral mesial temporal sclerosis (MTS). Methods: We identified 56 patients with magnetic resonance imaging-defined MTS who underwent MRgLiTT with at least 1 year of follow-up. Primary outcome was seizure freedom at 1 year. We examined the association of seizure freedom and the following clinical factors: age at surgery, gender, history of febrile seizures, history of focal to bilateral tonic–clonic seizures, duration of epilepsy at the time of surgery, frequency of interictal epileptiform discharges (IEDs), seizure frequency, and presence of bilateral IEDs. Results: Thirty-five (62.5%) patients were seizure-free at 1 year. The presence of bilateral IEDs and age at surgery were associated with 1-year seizure freedom after MRgLiTT. The presence of bilateral IEDS was associated with lower odds of seizure freedom (odds ratio [OR] =.05, 95% confidence interval [CI] =.01–.46, p =.008), whereas increasing age at surgery was associated with increased odds of seizure freedom (OR = 1.10, 95% CI = 1.03–1.19, p =.009). Significance: This study demonstrates associations between presence of bilateral IEDs and age at surgery and seizure freedom at 1 year after MRgLiTT.
AB - Objective: This study was undertaken to identify clinical factors associated with seizure freedom after magnetic resonance-guided laser interstitial thermal therapy (MRgLiTT) in temporal lobe epilepsy patients with unilateral mesial temporal sclerosis (MTS). Methods: We identified 56 patients with magnetic resonance imaging-defined MTS who underwent MRgLiTT with at least 1 year of follow-up. Primary outcome was seizure freedom at 1 year. We examined the association of seizure freedom and the following clinical factors: age at surgery, gender, history of febrile seizures, history of focal to bilateral tonic–clonic seizures, duration of epilepsy at the time of surgery, frequency of interictal epileptiform discharges (IEDs), seizure frequency, and presence of bilateral IEDs. Results: Thirty-five (62.5%) patients were seizure-free at 1 year. The presence of bilateral IEDs and age at surgery were associated with 1-year seizure freedom after MRgLiTT. The presence of bilateral IEDS was associated with lower odds of seizure freedom (odds ratio [OR] =.05, 95% confidence interval [CI] =.01–.46, p =.008), whereas increasing age at surgery was associated with increased odds of seizure freedom (OR = 1.10, 95% CI = 1.03–1.19, p =.009). Significance: This study demonstrates associations between presence of bilateral IEDs and age at surgery and seizure freedom at 1 year after MRgLiTT.
KW - MR-guided LiTT
KW - epilepsy surgery
KW - hippocampal sclerosis
KW - mesial temporal sclerosis
KW - surgery outcomes
UR - http://www.scopus.com/inward/record.url?scp=85102458331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102458331&partnerID=8YFLogxK
U2 - 10.1111/epi.16872
DO - 10.1111/epi.16872
M3 - Article
C2 - 33713425
AN - SCOPUS:85102458331
SN - 0013-9580
VL - 62
SP - 1085
EP - 1091
JO - Epilepsia
JF - Epilepsia
IS - 5
ER -